SC 13D

Company

LIPELLA PHARMACEUTICALS INC.

Filed

December 29, 2022

Accession Number

0001753926-22-001650

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →